Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-30

Clinical Trial Update: Efficacy and Safety of Chidamide in CBF Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update reports on the efficacy and safety of chidamide in patients with acute myeloid leukemia; the study is currently active but not recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chidamide (chidamide)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: AML | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING